| pubmed-article:10850360 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10850360 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:10850360 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:10850360 | lifeskim:mentions | umls-concept:C1979893 | lld:lifeskim |
| pubmed-article:10850360 | lifeskim:mentions | umls-concept:C0085101 | lld:lifeskim |
| pubmed-article:10850360 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:10850360 | pubmed:dateCreated | 2000-7-18 | lld:pubmed |
| pubmed-article:10850360 | pubmed:abstractText | This trial was conducted to assess the toxicity and efficacy of 131I-Lym-1 in patients with either malignant B-cell non-Hodgkin's lymphoma (NHL) or chronic lymphocytic leukemia (CLL) using low-dose, fractionated radioimmunotherapy (RIT). | lld:pubmed |
| pubmed-article:10850360 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10850360 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10850360 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10850360 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10850360 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10850360 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10850360 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10850360 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10850360 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10850360 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10850360 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:10850360 | pubmed:issn | 1084-9785 | lld:pubmed |
| pubmed-article:10850360 | pubmed:author | pubmed-author:LewisJ PJP | lld:pubmed |
| pubmed-article:10850360 | pubmed:author | pubmed-author:LevyN BNB | lld:pubmed |
| pubmed-article:10850360 | pubmed:author | pubmed-author:DeNardoG LGL | lld:pubmed |
| pubmed-article:10850360 | pubmed:author | pubmed-author:DeNardoS JSJ | lld:pubmed |
| pubmed-article:10850360 | pubmed:author | pubmed-author:MaceyD JDJ | lld:pubmed |
| pubmed-article:10850360 | pubmed:author | pubmed-author:ShenSS | lld:pubmed |
| pubmed-article:10850360 | pubmed:author | pubmed-author:LambornK RKR | lld:pubmed |
| pubmed-article:10850360 | pubmed:author | pubmed-author:GoldsteinD... | lld:pubmed |
| pubmed-article:10850360 | pubmed:author | pubmed-author:RaventosAA | lld:pubmed |
| pubmed-article:10850360 | pubmed:author | pubmed-author:O'GradyL FLF | lld:pubmed |
| pubmed-article:10850360 | pubmed:author | pubmed-author:McGahanJ PJP | lld:pubmed |
| pubmed-article:10850360 | pubmed:author | pubmed-author:KrogerL ALA | lld:pubmed |
| pubmed-article:10850360 | pubmed:author | pubmed-author:MillsS LSL | lld:pubmed |
| pubmed-article:10850360 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10850360 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:10850360 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10850360 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10850360 | pubmed:pagination | 239-54 | lld:pubmed |
| pubmed-article:10850360 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:10850360 | pubmed:meshHeading | pubmed-meshheading:10850360... | lld:pubmed |
| pubmed-article:10850360 | pubmed:meshHeading | pubmed-meshheading:10850360... | lld:pubmed |
| pubmed-article:10850360 | pubmed:meshHeading | pubmed-meshheading:10850360... | lld:pubmed |
| pubmed-article:10850360 | pubmed:meshHeading | pubmed-meshheading:10850360... | lld:pubmed |
| pubmed-article:10850360 | pubmed:meshHeading | pubmed-meshheading:10850360... | lld:pubmed |
| pubmed-article:10850360 | pubmed:meshHeading | pubmed-meshheading:10850360... | lld:pubmed |
| pubmed-article:10850360 | pubmed:meshHeading | pubmed-meshheading:10850360... | lld:pubmed |
| pubmed-article:10850360 | pubmed:meshHeading | pubmed-meshheading:10850360... | lld:pubmed |
| pubmed-article:10850360 | pubmed:meshHeading | pubmed-meshheading:10850360... | lld:pubmed |
| pubmed-article:10850360 | pubmed:meshHeading | pubmed-meshheading:10850360... | lld:pubmed |
| pubmed-article:10850360 | pubmed:meshHeading | pubmed-meshheading:10850360... | lld:pubmed |
| pubmed-article:10850360 | pubmed:meshHeading | pubmed-meshheading:10850360... | lld:pubmed |
| pubmed-article:10850360 | pubmed:meshHeading | pubmed-meshheading:10850360... | lld:pubmed |
| pubmed-article:10850360 | pubmed:meshHeading | pubmed-meshheading:10850360... | lld:pubmed |
| pubmed-article:10850360 | pubmed:meshHeading | pubmed-meshheading:10850360... | lld:pubmed |
| pubmed-article:10850360 | pubmed:meshHeading | pubmed-meshheading:10850360... | lld:pubmed |
| pubmed-article:10850360 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:10850360 | pubmed:articleTitle | Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibody. | lld:pubmed |
| pubmed-article:10850360 | pubmed:affiliation | University of California Davis Medical Center, Sacramento 95816, USA. | lld:pubmed |
| pubmed-article:10850360 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10850360 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10850360 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:10850360 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10850360 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10850360 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10850360 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10850360 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10850360 | lld:pubmed |
